Plain-English translation of NCT06286423 on ClinicalTrials.gov ↗ ·
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a medication called colchicine can help people who are hospitalized with acute heart failure—a condition where the heart suddenly can't pump blood effectively. Researchers believe this medication, which reduces harmful inflammation in the body, may help the heart recover better and prevent future complications. You would take the medication twice daily for two weeks, then once daily for about 2.5 months.
When the heart suddenly fails, harmful inflammation plays a major role in worsening damage. Early research shows this medication has successfully reduced inflammation and prevented serious heart problems like heart attacks and strokes in other heart patients, so doctors want to test whether it can help people during acute heart failure crises.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to receive either the medication or a placebo (inactive pill) that look identical. You'll take your assigned treatment twice daily for 14 days while still hospitalized, then once daily for about 2.5 more months at home. The study team will monitor your heart function, inflammation levels, and overall health through blood tests and follow-up visits to see if the medication helps you recover better.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States